Biotech Firm Seeks $96.6 Million Listing on New High-Tech Board
Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. has become the first Hong Kong-listed company to announce it wants to list on Shanghai’s new high-tech board.
The biotech company hopes to raise 650 million yuan ($96.6 million), after its board approved the issue of up to 120 million new A-shares at a price of 0.1 yuan each, it said in a statement on Friday.
The company now needs the approval of China’s securities regulator.
Early this month, the biotech sector was among 34 industries selected by regulators as favorites to list on the new board — others include semiconductors and integrated circuits, as well as artificial intelligence.
Other companies that plan to list on the new high-tech board include Jiangsu Beiren Robot System Co. Ltd., an industrial robot manufacturer, and Jiangxi JDL Environmental Protection Co. Ltd., which makes sewage treatment equipment.
The high-tech board was announced by President Xi Jinping in November in an effort to lure technology firms to list in the city in competition with overseas bourses. In March, the Shanghai Securities Exchange announced specifics on the implementation of the rules to list there. Such rules — such as a registration-based system — were seen as less rigid than those of the city’s main board, which has an approval system.
Founded in 1996, Shanghai-based Fudan-Zhangjiang manufactures and sells biopharmaceutical products. It listed in Hong Kong in 2002. Last year, it reported a net profit of 151 million yuan on revenue of 740 million yuan.
The company said if it raises 650 million yuan it will spend 240 million for research and development, with the remainder used to increase its stake in a subsidiary and to invest in a project in the United States.
Contact reporter Mo Yelin (firstname.lastname@example.org)
May 07 08:24 PM
May 07 07:51 PM
May 07 07:39 PM
May 07 04:35 PM
May 06 06:31 PM
May 06 06:25 PM
May 06 06:16 PM
May 05 06:52 PM
May 05 06:46 PM
May 05 06:43 PM
May 04 06:37 PM
May 04 06:34 PM
May 04 05:50 PM
Apr 30 07:05 PM
Apr 30 06:31 PM
- 1Sinopharm’s Vaccine Nears Emergency-Use Approval by WHO
- 2Patchy Risk Disclosure Earns Shanghai Pudong Development Bank a Slap on the Wrist
- 3State Rail Operator Blamed for Beijing Labor Day Chaos
- 4Major Chinese State Firms Told to Keep a Closer Eye on Their Derivative Trading
- 5Illegal Fuel Trade Probe Detains Six Employees of BP’s South China Venture
- 1Power To The People: Pintec Serves A Booming Consumer Class
- 2Largest hotel group in Europe accepts UnionPay
- 3UnionPay mobile QuickPass debuts in Hong Kong
- 4UnionPay International launches premium catering privilege U Dining Collection
- 5UnionPay International’s U Plan has covered over 1600 stores overseas